Allogenica is a biotechnology company developing an allogenic « off-the-shelf » CAR-T cells bioproduction platform. Allogenica’s ambition is to offer this next-generation cancer treatment ready to use, at low cost and safer than current treatments, in order to treat all patients in need. En savoir plus
